Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

lomerizine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The purpose of this study was to determine whether lomerizine, a Ca(2+) channel blocker, protects against neuronal degeneration… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2009
2009
Secondary degeneration is a form of 'bystander' damage that can affect neural tissue both nearby and remote from an initial… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
PURPOSE After partial optic nerve (ON) injury, intact retinal ganglion cells (RGCs) undergo secondary death, but the topographic… Expand
Is this relevant?
2009
2009
The therapeutic agents flunarizine and lomerizine exhibit inhibitory activities against a variety of ion channels and… Expand
  • figure 1
  • table 3
  • table 1
  • table 2
  • table 4
Is this relevant?
2009
2009
A 64-year-old woman was admitted to our hospital for recurrent stroke and cognitive impairment and was diagnosed with cerebral… Expand
Is this relevant?
2006
2006
Purpose: We investigated whether lomerizine, a new diphenylmethylpiperazine calcium channel blocker, exerted a neuroprotective… Expand
Is this relevant?
2003
2003
PURPOSE To investigate the effects of lomerizine, a Ca2+ antagonist, on the ocular tissue circulation in rabbits and on the… Expand
Is this relevant?
2001
2001
We examined the effects of lomerizine, a new diphenylmethylpiperazine Ca2+ channel blocker, on the normal circulation in the… Expand
Is this relevant?
2001
2001
Acquired resistance to chemotherapy is a major problem during cancer treatment. One mechanism for drug resistance is… Expand
Is this relevant?
2000
2000
We examined the effects of a new Ca2+ channel blocker, lomerizine, on the intraocular hypertension-induced ischemia/reperfusion… Expand
Is this relevant?